Peritoneal dialysis fluids (PDFs) impair microorganisms' growth, which may compromise effectivity of some antimicrobials. The purpose of this study was to investigate the effect of three different PDFs (lactate/bicarbonate-buffered Physioneal 40 R with 2.2% glucose, lactate-buffered Nutrineal PD4 R with 1.1% amino acid, and lactate-buffered Extraneal R with 7.5% icodextrin) on biofilm formation of four different Candida spp and antibiofilm effectiveness of anidulafungin, caspofungin and micafungin against Candida spp. biofilm in PDFs. All tested PDFs attained inhibitory effect on the biofilm formation but also reduced biofilm effectiveness of echinocandins against biofilm in PDFs was detected.
Introduction
Peritonitis is a common complication in patients with chronic kidney disease who are receiving treatment with peritoneal dialysis (PD). 1 The incidence of PD-associated peritonitis caused by fungi remains about 3%-6% 2,3 with
Candida species as the most common pathogen of fungal peritonitis accounting for 70%-90% of cases. 4 The role of biofilm formation in active PD-associated peritonitis is still unclear, but the presence of biofilms on PD catheters has been confirmed by retrospective studies. 5, 6 The therapy of biofilm-associated infection includes removal of medical devices and in some cases addition of systemic antifungal treatment. When prompt catheter or other medical device removal is not feasible, antifungal lock therapy combined with systemic administration of liposomal amphotericin B or caspofungin could represent a treatment option. 7 However, there are no data if this treatment option could be used for PD-associated peritonitis, and the delivery of drugs by the intraperitoneal route is preferable to intravenous or oral administration because it results in extremely high drug levels at the site of infection. Current peritoneal dialysis fluids (PDFs) used in clinical practice show differences in concentrations of glucose, lactate, bicarbonate, amino acids, and other constituents, and it is important that prescribed drugs are compatible with the respective PDF. In accordance with in vitro data, echinocandins show higher activity against Candida spp. biofilm than azoles and amphotericin B. 8 Therefore, the purpose of our study was to investigate the influence of PDFs on the biofilm formation and on the activity of echinocandins against biofilms of four different Candida spp. R with 1.1% amino acid and lactate-buffered Extraneal R with 7.5% icodextrin. As exipients all three PDF contain hydrochloric acid and/or sodium hydroxide (pH adjuster). The pH was adjusted to 7.4 with NaOH, corresponding to pH of used PDFs after a 4-6 h intraperitoneal dwell. RPMI 1640 medium with L-glutamine and without sodium bicarbonate (Sigma, Chemical Co, St Louis, MO, USA), buffered with 3-[N-morpholino]propanensulfonic acid (MOPS) (Sigma, Chemical Co) was used as the control fluid. Biofilm formation of Candida spp. and determination of biofilm inhibitory concentrations (MBICs) for anidulafungin (ANA), caspofungin (CAS), and micafungin (MIC) in PDFs were studied using microtiter plate model. 9 Biofilms was determined using XTT reduction assay. Two inoculums sizes: 3-5 × 10 6 cfu/ml (low inoculum) and 3-5 × 10 8 cfu/ml (high inoculum) were used for testing of biofilm formation in PDFs. For MBIC determination in the wells containing biofilms (high inoculum) 200 μl of echinocandins diluted in three different PDFs or in RPMI 1640 was added and incubated at 37
Material and methods
• C for 24 h. The minimum biofilm inhibitory concentration (MBIC) was defined as the lowest drug concentration that inhibited metabolic activity by 50% relative to the drug-free growth control well. 10 
Statistical analysis
Three wells with biofilm per isolate per each PDF and per each concentration of echinocandins were tested per experiment. The average values of these replicates were used in the data analysis to determine mean ± standard deviation for each condition. Each experiment was repeated at least three times on three different days. The difference in biofilm formation between different PDFs used was examined by the Wilcoxon rank-sum test. Data were analyzed using SPSS 22.0 software package. A two-tailed P value of < .05 was considered significant.
Results
Biofilm growth for all four Candida spp. was reduced in all three PDFs when compared to the control fluid (Fig. 1) . Compared to RPMI 1640 medium significantly less biofilm production for all four Candida spp was detected using low inoculum in three tested PDFs (OD 0.01-0.15 in all three PDFs vs. 0.33-0.84 in control, P < .05). Using high inoculum only icodextrin-based PDF proved to significantly reduce biofilm growth for all four Candida species (0.06-0.26 in Extraneal vs. 0.34-0.86 in control, P < .05). However, C. glabrata showed significantly less biofilm production in all PDFs compared to control fluid (0.06-0.11 in all three PDFs vs. 0.34 in control, P < .05).
MBICs of all three echinocandins were elevated in all three PDFs compared to the control fluid (Table 1) . Echinocandins showed the lowest MBIC of 2 μg/ml against C. glabrata in the icodextrin based PDF. In other PDFs MBICs of echinocandins against Candida spp. were between 32 μg/ml and >64 μg/ml.
Discussion
In the present study we showed that glucose-, amino acid-, and icodextrin-based PDFs support less biofilm production than control fluid usually used for in vitro biofilm testing. It seems that PDFs have a certain prophylactic effect on the formation of Candida biofilm for patients treated with PD. This phenomenon was seen using two different inoculums sizes. While PDFs inhibit biofilm production, echinocandins showed further decreases in biofilm production-though this reduction required relatively higher conentrations of echinocandins than while in the presence of the control fluid.
The reason of reduced biofilm activity of echinocandins in PDFs is unclear, but we have already reported less activity of echinocandins against planktonic cells using killing curves in PDFs.
11 Yet, in the tested PDFs, MBICs of all three echinocandins were elevated compared to the control fluid. Echinocandins showed the lowest MBIC of 2 μg/ml against C. glabrata in icodextrin-based PDF. However, C. glabrata seems to be a less effective biofilm producer in PDFs than other Candida spp., and icodextrin supports less biofilm production than other PDFs. In amino acid-and glucosebased PDFs MBICs of echinocandins against Candida spp. were between 32 μg/ml and >64 μg/ml. It is unclear why in PDFs that support less biofilm formation, also less activity of echinocandins compared to control fluid was seen. However, it seems that the efficacy of echinocandins against biofilm in PDFs is not dependent on the metabolic activity of the sessile cell measured by XTT assay. The echinocandins could be an attractive treatment option in patients with Candida spp. peritonitis, due to their broad-spectrum fungal activity but also high clinical efficacy and low rate of treatment-related adverse events. However, there is no pharmacokinetic data of echinocandins in PD patients. Only anecdotal reports are available concerning the intravenous use of these agents in the PD population, however in all reports PD-catheter was removed.
12-14 One limitation of our study was that the stability of antifungal drugs in PDFs was not tested, which may serve as an alternative explanation for the different activities of the study drugs in PDFs. However, we have already reported the stability of anidulafungin in PDFs, and it seems that stability is not a reason for less biofilm activity in PDFs, at least not for anidulafungin. 15 Other limitation is using only XXT assay for testing of biofilm formation, which measured metabolic activity. Considerable variability in biomass using crystal violet and metabolic activity using XXT assay was found both between species and within species. 16 Despite these limitations our results should have significant impact on both further studies and new guidelines for the treatment of fungal peritonitis associated with PD, especially if PD catheters are retained.
In conclusion, we have demonstrated that PDFs support less biofilm production, but also significantly impair the activity of echinocandins against Candida spp. biofilm.
